The make or buy debate: Considering the limitations of domestic production in Tanzania

Globalization and Health

Volumn 8, Issue , 2012, Pages

  Wilson, Kinsley R ^a   Kohler, Jillian C ^a   Ovtcharenko, Natalia ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NEVIRAPINE; STAVUDINE; ANTIRETROVIRUS AGENT;

DEVELOPING WORLD; DRUG DEVELOPMENT; ECONOMY OF SCALE; HEALTH POLICY; HEALTH SERVICES; IMPORT; INTELLECTUAL PROPERTY RIGHTS; MANUFACTURING; PHARMACEUTICAL INDUSTRY; PRICE DYNAMICS; PUBLIC ACCESS; TECHNOLOGY TRANSFER; TRADE AGREEMENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; TANZANIA; COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH SERVICES RESEARCH; TECHNOLOGY;

TANZANIA;

ANTI-RETROVIRAL AGENTS; COMMERCE; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; DRUG COSTS; DRUG INDUSTRY; ECONOMIC COMPETITION; HIV INFECTIONS; HUMANS; ORGANIZATIONAL CASE STUDIES; TANZANIA; TECHNOLOGY TRANSFER;

EID: 84863001635     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-8-20     Document Type: Article

References (44)

1. MSF (Médecins Sans Frontières) Untangling the web of price reduction: A pricing guide for the purchase of ARVs for developing countries 2007, MSF, Geneva, 10, Retrieved June 28, 2008, from www.accessmed-msf.org, MSF (Médecins Sans Frontières).
2. UNAIDS (Joint United Nations Programme on HIV/AIDS) 2010 Global Report: UNAIDS report on the global AIDS epidemic 2010, UNAIDS & World Health Organization, Geneva, UNAIDS (Joint United Nations Programme on HIV/AIDS).
3. UNAIDS (Joint United Nations Programme on HIV/AIDS) 2007 AIDS epidemic update 2007, UNAIDS & World Health Organization, Geneva, UNAIDS (Joint United Nations Programme on HIV/AIDS).
4. Matthews D. WTO decision on implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: A solution to the access to essential medicines problem?. J Int Econ Law 2004, 7:73-107.
5. World Trade Organization Text of the Agreement on Trade Related Aspects of Intellectual Property (TRIPs) 1994, , Lausanne, http://www.wto.org/english/docs_e/legal_e/legal_e.htm#TRIPs, World Trade Organization.
6. World Trade Organization Declaration on the TRIPS Agreement and Public health 2001, http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm, World Trade Organization.
7. World Trade Organization Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health 2003, http://www.wto.org/english/tratop_e/trips_e/implem_para6_e.htm, World Trade Organization.
8. Osewe PL, Nkrumah YK, Sackey EK. Improving Access to HIV/AIDS Medicines in Africa: Trade-related Aspects of Intellectual Property Rights Flexibilities 2008, World Bank, Washington, DC.
9. Viera MF, Reis R, Chaves G. Civil society strategy for the compulsory licensing of lopinavir/ritonavir: the Brazilian case. HIV/AIDS Policy and Law Review 2008, 13(2-3):80-81.
10. Saez C. Ecuador Grants First Compulsory Licence, For HIV/AIDS Drug. Intellectual Property Watch 2010, http://www.ip-watch.org/weblog/2010/04/22/ecuador-grants-first-compulsory-licence-for-hivaids-drug/.
11. Grace C. Leveraging the private health sector for public health objectives: A briefing paper for DFID [Department for International Development] on technology transfer in the pharmaceuticals sector 2004, Department for International Development's (DFID) Health Systems Resource Centre (HSRC), London.
12. Guimier JM, Lee E, Grupper M. Processes and Issues for Improving Access to Medicines: The evidence base for domestic production and greater access to medicines 2004, Department for International Development's (DFID) Health Systems Resource Centre (HSRC), London.
13. Bennett S, Quick JD, Velásquez G. Public-private roles in the pharmaceutical sector: Implications for equitable access and rational drug use 1997, World Health Organization, Geneva.
14. MSH (Management Sciences for Health) Managing drug supply: The selection, procurement, distribution and use of pharmaceuticals 1997, Kumarian Press, Bloomfield, CT, MSH (Management Sciences for Health).
15. African Union Pharmaceutical manufacturing plan for Africa 2007, Third session of the African Union Conference of Ministers of Health, Johannesburg, http://www.africa- union.org/root/au/Conferences/2007/october/sa/Pharmaceutical/Pharmaceutical%20Plan- CAMH%20MIN.%208(III).doc, African Union.
16. UN-OHRLLS (UN Office of the High representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States): Least Developed Countries: Country Profiles; http://www.unohrlls.org/en/ldc/related/62/.
17. World Bank: Tanzania. http://data.worldbank.org/country/tanzania..
18. Kaplan WA, Laing R. Local production of pharmaceuticals: Industrial policy and access to medicines. An overview of key concepts, issues and opportunities for future research [HNP Discussion Papers] 2005, World Bank, Washington DC.
19. Ezzy D. Qualitative analysis: Practice and innovation 2002, Routledge, London.
20. Johnson A, Sackett R. Direct systematic observation of behavior 1998, 301-332. AltaMira, Walnut Creek, CA, Bernard R.
21. Maskus K. Encouraging international technology transfer. [UNCTAD-ICTSD Issue Paper No .7] 2004, United Nations Centre for Trade and Development- International Centre for Trade and Sustainable Development, Chavanod, France, http://www.iprsonline.org/unctadictsd/docs/CS_Maskus.pdf.
22. UNCTAD (United Nations Conference on Trade and Development.) Draft international code of conduct on the transfer of technology, as at the close of sixth session of Conference on June 1998 1985, United Nations, Geneva, UNCTAD (United Nations Conference on Trade and Development.).
23. Attridge CJ, Preker AS. Improving access to medicines in developing countries: Application of new institutional economics to the analysis of manufacturing and distribution issues 2005, World Bank Group, Washington, DC, http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resource s/281627-1095698140167/AttridgeImprovingAccessFinal.pdf.
24. Kaplan WA, Laing R, Waning B, Levison L, Foster S. Is local production of pharmaceuticals a way to improve pharmaceutical access in developing and transitional countries? Setting a research agenda. Draft: Issues in pharmaceutical procurement 2003, Boston University School of Public Health, Boston, MA.
25. Rovira J. Creating and promoting domestic drug manufacturing capacities: A solution for developing countries?. Negotiating health. Intellectual property and access to medicines 2006, 227-240. Earthscan Publications Ltd, London, UK, Roffe P, Tansey G, Vivas-Eugui D.
26. UNIDO (United Nations Industrial Development Organization) Appropriate industrial technology for drugs and pharmaceuticals (Monographs on Appropriate Industrial Technology) 1980, , New York, UNIDO (United Nations Industrial Development Organization).
27. WHO (World Health Organization) Local production of essential medicines, including antiretrovirals: Issues, challenges and perspectives in the African region World Health Organization, Fifty-fifth Session Regional Committee for Africa Maputo, Mozambique, www.afro.who.int/rc55/documents/afr_rc55_10_local_production.pdf^ç, WHO (World Health Organization).
28. CHAI (Clinton HIV/AIDS Initiative) Antiretroviral (ARV) price list 2008, Clinton Foundation HIV/AIDS Initiative, New York, www.clintonfoundation.org/download/?guid = 62e82ddc-93de-102b-be34-001143e0d9b6, CHAI (Clinton HIV/AIDS Initiative).
29. MoHSW (Ministry of Health and Social Welfare) HIV/AIDS Care and Treatment Plan 2003-2008 2003, United Republic of Tanzania, Dodoma, www.nacptz.org/publications/NCTP%20-%20Document.pdf, MoHSW (Ministry of Health and Social Welfare).
30. UNAIDS (Joint United Nations Programme on HIV/AIDS) AIDS epidemic update 2008, UNAIDS & World Health Organization, Geneva, UNAIDS (Joint United Nations Programme on HIV/AIDS).
31. Ministry of Planning, Economy and Empowerment Macroeconomic POLICY FRAMEWORK for 2006/07-2008/09 2006, United Republic of Tanzania, Dar-es-Salaam, Tanzania, http://www.tanzania.go.tz/pdf/Macroeconomic%20policy%20final.pdf, Ministry of Planning, Economy and Empowerment.
32. TFDA (Tanzania Food and Drug Regulatory Authority) Strategies for promotion of local production of pharmaceuticals in Tanzania: A concept paper 2007, TFDA, Dar-es-Salaam, Tanzania, TFDA (Tanzania Food and Drug Regulatory Authority).
33. United Republic of Tanzania The Patents Act (No. 1 of 1987) http://www.wipo.int/wipolex/en/text.jsp?file_id = 130031, United Republic of Tanzania.
34. Business Registrations and Licensing Agency: Patents http://www.brela-tz.org/?section = patent.
35. Chien C. HIV/AIDS drugs for Sub-Saharan Africa: How do brand and generic supply compare?. PLoS One 2007, 2(3):e278. http://www.plosone.org/article/info:doi%2 F10.1371%2Fjournal.pone.0000278, 10.1371/journal.pone.0000278, 1805689, 17372625.
36. Porter ME, Schwab K. The global competitiveness report 2008-2009 2008, World Economic Forum, Geneva, http://www.weforum.org/documents/GCR0809/index.html.
37. Barney J. Anti-retrovirals: Fertile field for HIV research. Financial Times 2007, http://www.ft.com/cms/s/958e3890-9671-11 dc-b2da0000779fd2ac,Authorised = false.html?_i_location = http%3A%2 F%2Fwww.ft.com%2Fcms%2Fs%2 F1%2F958e3890-9671-11 dc-b2da-0000779fd2ac.html&_i_referer=.
38. Tanzania New pharmaceutical plant to produce ARVs 2012, PlusNews, , http://www.plusnews.org/Report/95023/TANZANIA-New-pharmaceutical-plant-to-produce-ARVs, Tanzania.
39. IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) IFPMA supports call for extension of TRIPS compliance deadline for Least Developed countries 2011, http://www.ifpma.org/fileadmin/content/News/2011/all/Release_TRIPS__extension_10Feb2011.pdf, IFPMA (International Federation of Pharmaceutical Manufacturers & Associations).
40. IFC (International Finance Corporation) The business of health in Africa: Partnering with the private sector to improve people's lives 2008, , Washington, DC, http://www.ifc.org/ifcext/healthinafrica.nsf/AttachmentsByTitle/IFC_HealthinAfrica_Final/$FILE/IFC_HealthinAfrica_Final.pdf, IFC (International Finance Corporation).
41. WHO Prequalification of medicines by WHO 2010, http://www.who.int/mediacentre/factsheets/fs278/en/index.html, WHO.
42. GPRM (Global Price Reporting Mechanism) Price and procurement data 2008, World Health Organization, Geneva, http://www.who.int/hiv/amds/gprm/en, GPRM (Global Price Reporting Mechanism).
43. Roche Roche engages in four additional AIDS Technology Transfers to strengthen local manufacturing in world's poorest countries http://www.roche.com/med-cor-2008-01-09, Roche.
44. Cohen-Kohler JC. The renovation of institutions to support drug access: Is it enough?. Innovation in global health governance: Critical cases 2009, 177-190. Ashgate, Aldershot, UK, Cooper AF, Kirton JJ.